Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
87
CIMA_AEMPS:87
Drug Approvals
NEUPOGEN 48 MU (0,96 mg/ml) SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
- Company
- AMGEN EUROPE B.V.
CIMA_AEMPS
AMGEVITA 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
- Approval Date
- Jul 14, 2025
- Company
- AMGEN EUROPE B.V.
CIMA_AEMPS
NEUPOGEN 30 MU (0,6 mg/ml) SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
- Company
- AMGEN EUROPE B.V.
CIMA_AEMPS
ARANESP 60 microgramos SOLUCION INYECTABLE EN PLUMA PRECARGADA
- Approval Date
- Jul 14, 2025
- Company
- AMGEN EUROPE B.V.
CIMA_AEMPS
ARANESP 60 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
- Company
- AMGEN EUROPE B.V.
CIMA_AEMPS
ARANESP 50 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
- Company
- AMGEN EUROPE B.V.
CIMA_AEMPS
ARANESP 50 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
- Company
- AMGEN EUROPE B.V.
CIMA_AEMPS
ARANESP 20 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
- Company
- AMGEN EUROPE B.V.
CIMA_AEMPS
ARANESP 15 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
- Company
- AMGEN EUROPE B.V.
CIMA_AEMPS
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)No trials found
News
No news found